with an altered expression of anti-and pro-apoptotic BCL-2 family members. In 1 3 7 particular, we found that the highly pro-apoptotic BIM short (BIM S) splice variant 1 3 8 accumulated in NK cells exposed to high concentrations of IL-15, suggesting a 1 3 9 mechanism by which these cells are prone to rapid apoptosis. These results shed new 1 4 0 light on the molecular mechanism of cytokine addiction in human NK cells following 1 4 1 3 9 8 proliferation. Corroborating the flow cytometry data in Figure 4C , we found that 3 9 9
BCL-2 expression was lower in proliferating than in non-proliferating NK cells when 4 0 0 treated with high-dose IL-15 ( Figure 6C ). We then followed the expression of the was more potent at inducing robust NK cell proliferation than IL-15 treatment for 9 4 9 0 days with a three-day lack of IL-15 (day 4-6). However, intermitting IL-15 treatment 
0 7
In summary, our results reveal a subset and proliferation-dependent alteration 5 0 8
in BCL-2/BIM ratios with increased levels of the toxic BIM S splice variant. Together 5 0 9
these changes sensitize IL-15 addicted NK cells to cytokine withdrawal leading to 5 1 0 apoptosis. These insights may pave the way for gene-editing approaches aiming to 5 1 1 restore BCL-2/BIM ratios or interfering with BIM S or its downstream targets prior to 5 1 2 adoptive transfer to prolong the in vivo persistence of expanded NK cell products.
1 3
Alternatively, it may be possible to rescue the addicted phenotype by titrating the 5 1 4
level of IL-15 before in vivo infusion of the final cell therapy product. C  l  e  a  r  a  n  c  e  o  f  B  C  e  l  l  L  y  m  p  h  o  m  a  s  .  C  l  i  n  i  c  a  l  c  a  n  c  e  r  r  e  s  e  a  r  c  h  :  a  n  o  f  f  i  c  i  a  l  5  7  0  j  o  u  r  n  a  l  o  f  t  h  e  A  m  e  r  i  c  a  n  A  s  s  o  c  i  a  t  i  o  n  f  o  r  C  a  n  c  e  r  R  e  s  e  a  r  c  h  2  2  :  5  9  6  -6  0  8  .  5  7  1  1  2  .  P  o  s  t  ,  M  .  ,  A  .  C  u  a  p  i  o  ,  M  .  O  s  l  ,  D  .  L  e  h  m  a  n  n  ,  U  .  R  e  s  c  h  ,  D  .  M  .  D  a  v  i  e  s  ,  M  .  B  i  l  b  a  n  ,  5  7  2  B  .  S  c  h  l  e  c  h  t  a  ,  W  .  E  p  p  e  l  ,  A  .  N  a  t  h  w  a  n  i  ,  D  .  S  t  o  i  b  e  r  ,  J  .  S  p  a  n  h  o  l  t  z  ,  E  .  C  a  s  a  n  o  v  a  ,  5  7  3  a  n  d  E  .  H  o  f  e  r  .  2  0  1  7  .  T  h  e  T  r  a  n  s  c  r  i  p  t  i  o  n  F  a  c  t  o  r  Z  N  F  6  8  3  /  H  O  B  I  T  R  e  g  u  l  a  t  e  s  5  7 V  i  a  n  t  ,  C  .  ,  S  .  G  u  i  a  ,  R  .  J  .  H  e  n  n  e  s  s  y  ,  J  .  R  a  u  t  e  l  a  ,  K  .  P  h  a  m  ,  C  .  B  e  r  n  a  t  ,  W  .  G  o  h  ,  Y  .  6  6  6  J  i  a  o  ,  R  .  D  e  l  c  o  n  t  e  ,  M  .  R  o  g  e  r  ,  V  .  S  i  m  o  n  ,  F  .  S  o  u  z  a  -F  o  n  s  e  c  a  -G  u  i  m  a  r  a  e  s  ,  S  .  6  6  7  G  r  a  b  o  w  ,  G  .  T  .  B  e  l  z  ,  B  .  T  .  K  i  l  e  ,  A  .  S  t  r  a  s  s  e  r  ,  D  .  G  r  a  y  ,  P  .  D  .  H  o  d  g  k  i  n  ,  B  .  B  e  u  t  l  e  r  ,  6  6  8  E  .  V  i  v  i  e  r  ,  S  .  U  g  o  l  i  n  i  ,  a  n  d  N  .  D  .  H  u  n  t  i  n  g  t  o  n  .  2  0  1  7  .  C  e  l  l  c  y  c  l  e  p  r  o  g  r  e  s  s  i  o  n  6  6  9  d  i  c  t  a  t  e  s  t  h  e  r  eu  i  r  e  m  e  n  t  f  o  r  B  C  L  2  i  n  n  a  t  u  r  a  l  k  i  l  l  e  r  c  e  l  l  s  u  r  v  i  v  a  l  .  T  h  e  6  7 
Figure legends

